Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Personalized Medicine...

<< Previous

Bullboard Posts

Next >>

Comment by BayStreetWildon Feb 07, 2023 1:29pm

111 Views

Post# 35272272

RE:RE:Personalized Medicine...

only half a year to go before another financing is needed it seems. Tick tock

oilandgasman wrote: Problem being this chubby Dr can't run a trial to save his life without grad students.
50 and counting..just 100 more to go Scotty McShilling.

years to go..not months